KA/EN
Register
Medicines reference
Search
Search
Product

Nobivac Puppy DP

Favourites

Canine distemper virus + Canine parvovirus · Intervet International B.V.

1 form: suspension. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
Suspension · Dog Dog 1 ml
Reconstitute and inject one 1 ml dose subcutaneously at 6 weeks of age; bring to 15-25 C before use and use within 30 minutes. Vaccinate healthy animals only; maternal antibodies may reduce the response. Injection-site or hypersensitivity reactions, including systemic signs and collapse, are very rare. Do not mix except with the specified solvent or compatible Nobivac leptospirosis vaccines described in the SPC.
 · one dose at 6 weeks of age		 one dose at 6 weeks of age Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ნობივაკი Puppy DP
№ 40-11; 274-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Nobivac Puppy DP, Suspension

lyophilisate for injection, 1 ml dose for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.4/10
Very good
vetman assessment

Nobivac Puppy DP

lyophilisate for injection, 1 ml dose for dogs
Assessed clinical scopeDog · Full puppy label: early active immunisation against canine distemper and parvovirus at 6 weeks, followed by completion of the standard core-vaccination programme · Subcutaneous
Care settingEarly puppy vaccination after examination and risk assessment, with cold-chain control and emergency treatment available
vetman score 8.4/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 40-11; 274-11 · Verified on 21 Oct 2026

A strong, well-documented early-life bridge for distemper and parvovirus risk. It earns its value only when the later guideline-concordant puppy series is completed; it must not be presented as a one-dose full programme.

Regulatory and scientific credibility9.0/10

The exact 1 ml presentation is registered in Georgia and has current regulator product information defining live strains, potency, six-week use, follow-on schedule, compatibility and adverse reactions.

Clinical efficacy8.2/10

CDV and CPV are strongly supported global core targets and the high-titre product provides useful early protection in high-risk puppies. Maternal antibody can still block response, and this single early dose is a bridge rather than a complete puppy series.

Safety and tolerability8.3/10

The live attenuated vaccine has a favourable profile in healthy puppies; injection-site and systemic reactions are uncommon to very rare, but hypersensitivity including collapse can require immediate treatment.

Clinical practicality7.8/10

A fixed 1 ml SC dose is simple and can fit high-risk early-life protocols, but reconstitution, 30-minute use, cold chain and mandatory follow-on core doses make it an added visit rather than a stand-alone solution.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Vaccinate healthy puppies only; do not use in hypersensitivity to a component.
  • This six-week dose is not a complete puppy course; continue the standard CDV/CPV series through 16 weeks or later as risk requires.
  • Maternal antibodies can reduce or block the response, especially to parvovirus; do not assume protection from one early dose.
  • Very rare hypersensitivity, systemic signs or collapse require immediate treatment and post-vaccination observation.
  • Mix only with the specified solvent or compatible Nobivac leptospirosis vaccines explicitly described in the SPC.
  • Maintain the cold chain, bring to the labelled temperature range, reconstitute aseptically and use within 30 minutes.
  • Reserve the early bridge for puppies whose exposure risk justifies an added visit; continue routine preventive care and isolation advice.
Assessment sources
  1. EU UPD SPC 20262026
  2. WSAVA vaccination 20242024
  3. AAHA canine vaccination 20222022
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Canine distemper virus5 log10 TCID50/dose Canine parvovirus7 log10 TCID50/dose
Formulation Type
Suspension
Administration route
Subcutaneous
Manufacturer
Intervet International B.V. · Netherlands
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ნობივაკი Puppy DP
№ 40-11; 274-11
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml
Reconstitute and inject one 1 ml dose subcutaneously at 6 weeks of age; bring to 15-25 C before use and use within 30 minutes. Vaccinate healthy animals only; maternal antibodies may reduce the response. Injection-site or hypersensitivity reactions, including systemic signs and collapse, are very rare. Do not mix except with the specified solvent or compatible Nobivac leptospirosis vaccines described in the SPC.
 Dog Any weight Subcutaneous one dose at 6 weeks of age
EU UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Nobivac Puppy DP - official product information
EU Union Product Database, 2026

Canine distemper virus: No dose supported by a publicly verifiable source yet

Canine parvovirus: No dose supported by a publicly verifiable source yet

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗